Sponsored by:

Nuclear Medicine: Page 432

International Isotopes gets FDA OK
By AuntMinnie.com staff writers
August 10, 2000
Positron builds revenue, shrinks loss in Q2
By AuntMinnie.com staff writers
August 7, 2000
Cytogen revenues slip in Q2
By AuntMinnie.com staff writers
August 7, 2000
International Isotopes announces management team
August 6, 2000
Radiopharmaceutical market may double by 2006, according to Frost & Sullivan report
By Erik L. Ridley
The U.S. radiopharmaceutical market could grow substantially in the next several years, says a new report by Frost & Sullivan, but only if therapeutic benefits are clearly communicated.
August 1, 2000
Mallinckrodt to offer ProstaSeed
By AuntMinnie.com staff writers
August 1, 2000
ADAC results surge in Q3
By AuntMinnie.com staff writers
July 27, 2000
Syncor revenues, income surge in Q2
By AuntMinnie.com staff writers
July 26, 2000
PET outperforms CT in detecting non-small-cell lung lesions
By Shalmali Pal
FDG-PET scanning outdoes CT in the detection of local and distant metastases in patients with non-small-cell lung cancer, according to Dutch researchers reporting in the July 27 New England Journal of Medicine.
July 25, 2000
PET scanning useful in neonatal heart patients, researchers say
By Shalmali Pal
Cardiac PET scanning offers a reliable, noninvasive method for evaluating coronary abnormalities in very young patients, starting in the first month after birth. Researchers from the University of California, Los Angeles used FDG and ammonia-13 PET studies to assess myocardial viability in children with suspected heart defects, and tested PET's effectiveness against histologic findings.
July 24, 2000
Marconi develops oncology screening tools
By AuntMinnie.com staff writers
July 23, 2000
Apomate kit pinpoints viable cells after myocardial damage
By AuntMinnie.com staff writers
July 23, 2000
Previous Page
Page 432 of 440
Next Page